Adicet Bio Inc (ACET)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -36,678 | -28,138 | -9,299 | -33,778 | 0 |
| Depreciation Amortization | 1,365 | 1,041 | 1,222 | 5 | 0 |
| Accounts payable and accrued liabilities | -814 | 527 | -282 | 1,392 | N/A |
| Other Working Capital | -13,524 | 341 | -8,046 | 4,265 | 0 |
| Other Operating Activity | 8,099 | -1,653 | -1,775 | 17,131 | 0 |
| Operating Cash Flow | $-41,552 | $-27,882 | $-18,180 | $-10,985 | $0 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 52,093 | -46,979 | -15,182 | N/A | N/A |
| PPE Investments | -990 | -952 | -876 | -44 | 0 |
| Net Acquisitions | 64,114 | N/A | N/A | N/A | 0 |
| Investing Cash Flow | $115,217 | $-47,931 | $-16,058 | $-44 | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 460 | 30 | 221 | 0 | N/A |
| Other Financing Activity | -157 | 76,915 | 10,825 | 64,378 | 0 |
| Financing Cash Flow | $303 | $76,945 | $11,046 | $64,378 | $0 |
| Beginning Cash Position | 14,889 | 13,757 | 36,949 | N/A | 0 |
| End Cash Position | 88,857 | 14,889 | 13,757 | 53,349 | 0 |
| Net Cash Flow | $73,968 | $1,132 | $-23,192 | $53,349 | $0 |
| Free Cash Flow | |||||
| Operating Cash Flow | -41,552 | -27,882 | -18,180 | -10,985 | 0 |
| Capital Expenditure | -990 | -1,070 | -876 | -44 | N/A |
| Free Cash Flow | -42,542 | -28,952 | -19,056 | -11,029 | 0 |